Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
QAS.AI logo — Artificial Intelligence driven optimization of neurovascular...

QAS.AI

Artificial Intelligence driven optimization of neurovascular treatments.

Founded 2020 United States Buffalo, United States 4 employees Grant AI, Health Care +2

General Information

Company Name QAS.AI
Founded Year 2020
Location United States Buffalo, United States
Employees 4
Industries AI, Health Care, Life Sciences +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with QAS.AI. To contact QAS.AI, visit qas.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does QAS.AI compare?

A PDF of QAS.AI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting QAS.AI soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About QAS.AI

QAS.AI is focused on optimizing endovascular treatments of neurovascular conditions by providing artificial intelligence driven intra-operative guidance to clinicians. The algorithms use angiographic imaging that is routinely acquired during an endovascular procedure and provides feedback regarding the future success or failure rate within 250 milliseconds. This allows clinicians to gain confidence in their treatment or reassess and adjust the treatment while the patient is still on the operating table. Currently, the algorithms can predict the future 6-month occlusion outcome of endovascularly treated intracranial aneurysms, and can detect the level of tissue perfusion of a patient undergoing mechanical thrombectomy for a large vessel occlusion ischemic stroke. The mission of the company is driven by the needs of neuro-surgeons and -interventionalists worldwide. QAS.AI has been backed by world renowned clinicians at University at Buffalo Neurosurgery (UBNS), and University of South Florida. In employment to further the technology and bring these algorithms to the clinic are respected MDs and PhDs in the field of Neurosurgery, Medical Physics, Biomedical Engineering, Artificial Intelligence, Biophysics and Pathology. QAS.AI has been recognized as a promising small business and awarded funding by the National Science Foundation in the form of Small Business Technology Transfer (STTR) and Innovation Corps (I-Corps) grants. It has also been supported by the University at Buffalo and the headquarters currently reside in a startup incubator at the Center of Excellence in Bioinformatics and Life Sciences (CBLS).

No funding data available for QAS.AI yet.

FAQ About QAS.AI

Artificial Intelligence driven optimization of neurovascular treatments.
QAS.AI was founded in 2020.
QAS.AI is headquartered in Buffalo, United States.
QAS.AI operates in AI, Health Care, Life Sciences and Clean Energy.
QAS.AI has approximately 4 employees.

We're actively collecting intelligence on QAS.AI.

Source: BounceWatch company record for QAS.AI, https://bouncewatch.com/company/qasai, updated 18 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes